Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Several injured as man threatens attack on German high-speed train - 2Apollo's impatient old-timers are rooting for NASA's return to the moon with Artemis II launch
- 3Radiated Tortoise Faces Rapid Decline in Madagascar
- 47 Moves toward a Sound and Dynamic Way of life
- 5Iran-backed militias reassert power in Iraq, proving the Islamic axis is still standing
- Support Your Body: A Manual for Smart dieting and Sustenance
- New India programme supports tribal families hosting tourists
- 12 times rockets and spacecraft crashed and burned in 2025
- Katz to Hezbollah chief Qassem: You won't live to see Israel’s full response to Passover attacks
- Vote In favor of Your Number one Savvy Beds
- A Time of Careful Eating: Individual Tests in Nourishment
- ‘Downton Abbey: The Grand Finale’ hits streaming: How to watch, cast info and everything you need to know
- Vote in favor of the wide open action that revives your brain and soul!
- NASA, in a rare move, cuts space station mission short after an astronaut's medical issue
